OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,095 | -23.9% | 2,353 | +1.3% | 0.00% | – |
| Q1 2024 | $21,139 | +116.4% | 2,323 | +6.1% | 0.00% | – |
| Q4 2023 | $9,767 | -61.5% | 2,190 | -72.9% | 0.00% | – |
| Q3 2023 | $25,346 | -39.1% | 8,072 | 0.0% | 0.00% | – |
| Q2 2023 | $41,652 | +143527.6% | 8,072 | +44.9% | 0.00% | – |
| Q1 2023 | $29 | +81.2% | 5,572 | 0.0% | 0.00% | – |
| Q4 2022 | $16 | -99.9% | 5,572 | +1.3% | 0.00% | – |
| Q3 2022 | $20,000 | -9.1% | 5,500 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | +1000.0% | 5,500 | +1000.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -12.5% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |